| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/18/2007 | US20070015839 Daily Dosage Regimen for Treating Diabetes, Obesity, Metabolic Syndrome and Polycystic Ovary Syndrome |
| 01/18/2007 | US20070015838 Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure |
| 01/18/2007 | US20070015837 Treatment of Cancer |
| 01/18/2007 | US20070015836 Modafinil synthesis process |
| 01/18/2007 | US20070015834 Formulations of fenofibrate containing PEG/Poloxamer |
| 01/18/2007 | US20070015833 Formulations of fenofibrate containing menthol |
| 01/18/2007 | US20070015832 Methods of treating overactive bladder and urinary incontinence |
| 01/18/2007 | US20070015831 Diclofenac formulations and methods of use |
| 01/18/2007 | US20070015830 Use of a retinoid type compound to modulate in vivo the decoupling activity of the protein UCP2 |
| 01/18/2007 | US20070015829 Derivatives of seleno-amino acids |
| 01/18/2007 | US20070015828 Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof |
| 01/18/2007 | US20070015827 Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation |
| 01/18/2007 | US20070015826 chromium(III) complexes coordinated with amino acids especially phenylalanine; to decrease plasma cholesterol and/or triglycerides |
| 01/18/2007 | US20070015824 Side effects reduction; depression, fibromyalgia, anxiety, panic disorder, agoraphobia, post traumatic stress disorder, premenstrual dysphoric disorder, attention deficit disorder, obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, autism, schizophrenia, obesity |
| 01/18/2007 | US20070015823 Ambruticin VS compounds |
| 01/18/2007 | US20070015822 Methods for selectively treating COX-2 mediated disorders by administering gamma-tocopherol |
| 01/18/2007 | US20070015821 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds |
| 01/18/2007 | US20070015820 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/18/2007 | US20070015819 Novel compounds |
| 01/18/2007 | US20070015818 Cyclic sulfone containing retroviral protease inhibitors |
| 01/18/2007 | US20070015817 4-((4-(2-pyrrolidinylethoxy)phenyl)methyl)-3-(4-(trifluoromethyl)phenyl)-7-hydroxychromen-2one, pharmaceutically acceptable salts thereof and methods of use therewith |
| 01/18/2007 | US20070015816 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
| 01/18/2007 | US20070015815 Hydrazide substrate shuts down protein biosynthesis capability in cells that host a metastatic or malignant disease mechanism |
| 01/18/2007 | US20070015814 Parp Modulators and Treatment of Cancer |
| 01/18/2007 | US20070015813 Treatment of protein folding disorders |
| 01/18/2007 | US20070015812 Factor Xa inhibitors |
| 01/18/2007 | US20070015811 5(S)-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments |
| 01/18/2007 | US20070015810 5(R)-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments |
| 01/18/2007 | US20070015809 Substituted pyrazoles, indazoles, 1,2,3-triazoles, or benzotriazoles; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations; aralkylation and amidation of the indazole compound |
| 01/18/2007 | US20070015808 Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3. 1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride |
| 01/18/2007 | US20070015807 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
| 01/18/2007 | US20070015805 Process for preparing 3-arylmethylthio- and 3-heteroarylmethylthio-4,5-dihydroisoxazoline derivatives |
| 01/18/2007 | US20070015804 Protease inhibitor; viricides; purity; crystal structure; mixing tank |
| 01/18/2007 | US20070015803 Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 01/18/2007 | US20070015802 Inhibitors of cyclin dependent kinases and their use |
| 01/18/2007 | US20070015801 Bactericides; (5R)-(-)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinecarboxamide |
| 01/18/2007 | US20070015800 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 01/18/2007 | US20070015799 Glyoxalase inhibitors |
| 01/18/2007 | US20070015798 Efficient and stereoselective process for large scale synthesis of (3R)-3-(2,3-dihydrobenzofuran-5-yl)-1,2,3,4-tetrahydropyrrolo[3,4-b]quinolin-9-one derivatives |
| 01/18/2007 | US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/18/2007 | US20070015796 Compositions and methods for treatment of fibrosis |
| 01/18/2007 | US20070015794 Endothelial growth factor; angiogenesis inhibitors; antitumor agents; skin disorders; endimetriosis; Crohn's disease; leukemia; antiarthritic agents |
| 01/18/2007 | US20070015793 Synthesis of nojirimycins |
| 01/18/2007 | US20070015792 Having at the 1-position a {spiro[4.5]dec-6-yl, spiro[2.5]oct-4-yl, spiro[3.5]non-5-yl, bicyclo[2.2.1]hept-2-yl, or 1-spiro(bicyclo[2.2.1]heptane-2,1'-cyclopropan)-3-yl} methyl group; nociceptin receptor Opioid receptor-like-1 receptor antagonists; analgesics, antidepressants; neurodegenerative diseases |
| 01/18/2007 | US20070015791 4-[2-dimethylamino-1-(4-hydroxy-phenyl)-ethyl]-piperidin-4-ol; lower undesirable side-effects; treating irritable bowel syndrome, premature ejaculation and urinary incontinence |
| 01/18/2007 | US20070015790 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| 01/18/2007 | US20070015789 Novel methods using aminobenzoic acid compounds |
| 01/18/2007 | US20070015788 N-(3-Aryl-3-substitutedphenylpropyl) piperidines or 8-azabicyclo[3.2.1]octanes that are additionally substituted with an optionally fused 5-member N-heterocycle; the compounds are modulators of CCR5 receptor activity and are used in treating diseases such as rheumatoid arthritis |
| 01/18/2007 | US20070015787 Apoptosis promoters |
| 01/18/2007 | US20070015786 Treatment of hot flashes, impulse control disorders and personality change due to a general medical condition |
| 01/18/2007 | US20070015785 Crystalline Micronisate, Process for the Manufacture Thereof and Use Thereof for the Preparation of a Medicament |
| 01/18/2007 | US20070015784 Subsitituted 1,4,8- triazaspiro [4,5]decan-2-one compounds |
| 01/18/2007 | US20070015783 Substituted 1,4,8-triazaspiro[4,5]decan-2-one compounds |
| 01/18/2007 | US20070015782 Benzimidazole compound |
| 01/18/2007 | US20070015781 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
| 01/18/2007 | US20070015780 Method of treating cancer with azaspirane compositions |
| 01/18/2007 | US20070015779 [1-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-3,5-disubstituted-1H-pyrazol-4-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; p38 map kinase inhibitors |
| 01/18/2007 | US20070015778 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/18/2007 | US20070015777 Use of Inhibitors of the Ubiquitin Proteasome Pathway as a Method of Increasing Contractility of the Heart |
| 01/18/2007 | US20070015776 Kinase Inhibitors |
| 01/18/2007 | US20070015775 Heterocyclic compounds |
| 01/18/2007 | US20070015774 Quinazoline derivatives useful in cancer treatment |
| 01/18/2007 | US20070015773 Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders |
| 01/18/2007 | US20070015772 Nucleoside metabolism inhibitors |
| 01/18/2007 | US20070015771 Lonidamine analogs |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015768 Ubiquitin ligase inhibitors and methods related thereto |
| 01/18/2007 | US20070015767 treating with hot water; pancreatic and prostate cancer |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015765 5-(2-pyrazinyl)-4methyl-1,2-dithiol-3-thione (Oltipraz) and its metabolites; neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 01/18/2007 | US20070015764 Inhibits hepatitus virus replication; useful in therapeutic and prophylactic treatment of hepatitis C virus |
| 01/18/2007 | US20070015763 Treatment of psychosis associated with parkinson's disease and subcortical dementias using a combination of an atypical antipsychotic with a dopamine agonist |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015761 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/18/2007 | US20070015760 Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates |
| 01/18/2007 | US20070015759 Metasubstituted thiazolidinones, their manufacture and use as a drug |
| 01/18/2007 | US20070015758 Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 01/18/2007 | US20070015757 Novel Glucagon Antagonists/Inverse Agonists |
| 01/18/2007 | US20070015756 For therapy of hyperproliferative diseases |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015754 (R)-N-(amino(1-(naphthalene-1-yl)ethylamino)methylene)-5-methyl-3-phenylisoxazole-4-carboxamide; amyloid precursor protein inhibitor; Alzheimer's disease |
| 01/18/2007 | US20070015753 crystallization of linezolid antibacterial agent in solvent and antisolvent |
| 01/18/2007 | US20070015752 Biaryl compositions and methods for modulating a kinase cascade |
| 01/18/2007 | US20070015751 Nitro and amino substituted heterocycles as topoisomerase I targeting agents |
| 01/18/2007 | US20070015750 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 01/18/2007 | US20070015749 Use of Substituted Pteridines for the treatment of respiratory diseases |
| 01/18/2007 | US20070015748 Kinase Inhibitors |
| 01/18/2007 | US20070015747 Respiratory syncytial virus replication inhibitors |
| 01/18/2007 | US20070015746 Azepine derivaties as pharmaceutical agents |
| 01/18/2007 | US20070015745 e.g. 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; antidiabetic agent, obesity |
| 01/18/2007 | US20070015744 Benzimidazolone and dihydroindolone derivatives and uses thereof |
| 01/18/2007 | US20070015743 Quinazoline derivatives as antitumor agents |
| 01/18/2007 | US20070015742 Porphyrin derivatives |
| 01/18/2007 | US20070015741 Novel prodrugs of estradiol |
| 01/18/2007 | US20070015740 Derivative prodrugs of ethinyl estradiol |
| 01/18/2007 | US20070015739 Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores |
| 01/18/2007 | US20070015738 Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells |
| 01/18/2007 | US20070015737 Compounds for inhibiting diseases and preparing cells for transplantation |
| 01/18/2007 | US20070015736 Filling plastic container with bisphosphonate solution; heat sterilization |
| 01/18/2007 | US20070015735 Water-dispersible carotenoids, including analogs and derivatives |